In this Market Access Podcast episode, Dr. Stefan Walzer sits down with Prof. Zanfania Ademi, a health economist at Monash University, to explore how Australia’s healthcare system is tackling key issues in market access and health technology assessment. Discover how Australia blends international approaches and new methods being developed by Zanfina and her team like distributional cost-effectiveness and productivity-adjusted life years to advance equity and value in healthcare. Tune in for fresh insights on health as an investment, not just a cost, and what’s next for decision-makers.
Key takeaways from the episode include the shift from qualitative to quantitative measures of equity in HTA, and the use of complex disease models and real-world evidence to drive smarter prevention strategies. The discussion also covers the growing recognition of both paid and unpaid work in productivity metrics, along with lessons from Switzerland on disinvestment, transparency, and the challenges of implementing new value measures in healthcare. Perfect for professionals in market access, health economics, and policy.